This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...